Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-022520

Director bought 11,000 shares at $5.27 ($57,970)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-23 Purchase : show line 1 in the form +11,000 $5.27 $57,970 4,834,286 I
Open-market purchases · 11,000 sh · avg $5.27 · $57,970
Loading xslF345X03/doc1.xml…